Brazil ’s health regulator Anvisa said in a statement that it authorised Sao Paulo ’s Butantan Institute biomedical centre to import 6m doses of a coronavirus vaccine candidate developed by China ’s Sinovac . 
The vaccine , known as Corona Vac , is still in phase 3 clinical trials in Brazil and has not been registered for wider use in Brazil , Anvisa said . 
